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Background and Objective: Airway macrophages perform the crucial functions of
presenting antigens, clearing pathogens, and apoptotic cells. Macrophage phagocytosis
is increased in adults with mild asthma and allergen exposure is known to activate
macrophages. However, it is not clear whether the mechanism behind this is due to
a primary defect or environmental factors such as allergen or lipopolysaccaride (LPS)
exposure. Our aim was to assess the phagocytic function of airway macrophages in
children with mild to moderate asthma after residence in a low allergen\LPS environment
at high altitude.
Methods: Sputum induction was performed in children with asthma at baseline and
after residence for a 3 weeks’ period at a high-altitude asthma center that has very low
ambient allergen levels. The markers of eosinophilic inflammation (including percentage
of macrophage cytoplasm with red hue) and phagocytosis of fluorescein isothiocyanate-
labeled, heat-killed Staphylococcus aureus by airway macrophages was analyzed.
Internalized bacteria were quantified using confocal microscopy.
Results: The median bacterial count [mean (standard deviation)] per macrophage was
significantly lower [39.55 (4.51) vs. 73.26 (39.42) (p = 0.006)] after residence at high
altitude. No association was observed between markers of eosinophilic inflammation
and bacterial phagocytosis.
Conclusions: The results suggest that the mechanism behind the enhanced
phagocytosis of bacteria in childhood asthma may be secondary to allergen or possibly
LPS exposure.
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INTRODUCTION
In recent years, knowledge of macrophage biology has vastly improved. The normally protective
alveolar macrophages can turn into pathogenic cells in adverse lung environment demonstrating
their plasticity (1). The transcriptome and epigenetic landscape of tissue macrophages have been
demonstrated as being determined by the tissue-specific microenvironment. Macrophages are
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constantly sensing the milieu of the adjacent stroma to regulate
the tissue homeostasis both during steady and inflammatory
states. (2). Lavin at all have shown that local tissue environment
can alter the macrophages to acquire the identity and function of
tissue residentmacrophages e.g., transfer of bonemarrow derived
alveolar macrophages or mature peritoneal macrophages into
alveolar space converted to alveolar macrophage-like cells (3).
Irrespective of the origin of macrophages (fetal, adult or
differentiated tissue) once in lung environment they can fully
function as alveolar macrophages and are similar at genomic and
epigenomic levels (4, 5). Various studies have revealed that the
development and resolution of lung injury is accompanied by
remarkable changes in the numbers and types of macrophages
(6, 7).
The lung is exposed to the environmental toxins like,
microorganisms, chemical agents (including environmental
LPS), allergens, and antigens. The alveolar and airway
macrophages perform a dual role of activation and suppression
of inflammation (8).
Asthma research has long been focused on cells that appear
to be the major contributors of airway inflammation, including
eosinophils, neutrophils, and lymphocytes. However, few studies
have endorsed the mechanisms of function and regulation of
macrophages that may orchestrate the inflammatory process.
Macrophages are front line defenders of innate immunity and
also play a crucial role in organ development, tissue turnover, and
regeneration (9). The macrophages are capable of sensing viral,
microbial, parasitic antigens, immune complexes, and apoptotic
or necrotic cells which helps in immune surveillance (9–11).
Airway macrophage phagocytosis in adults with mild asthma
is increased compared to healthy individuals and is possibly
related to higher levels of activation of macrophages (12). The
enhanced phagocytic function could be related to increased
levels of cysteinyl leukotrienes in allergic lung (13) or other
inflammatory mechanisms. However, Alexis et al. (12) observed
adults with mild asthma, and those with higher eosinophil counts
had lower phagocytosis (12). This suggests that macrophage
phagocytic functionmay be related to an interaction with allergen
and eosinophilic inflammation. Thus far, there have been no
studies on allergen exposure reduction to test this as a possible
cause of enhanced phagocytosis. In addition, LPS is well known
to activate macrophages resulting in increased chemotactic and
phagocytic activity (14) and therefore reduction of LPS would
reduce phagocytic activity.
Because of the low relative humidity at high altitudes, the
environment is free of house dust mites and molds (15). A
number of studies in children (16–20) and adults with asthma
have revealed a beneficial effect of high altitude residence on
symptoms, lung function, and eosinophilic inflammation (21).
However, no study has explored the effect of high altitude on
macrophage phagocytosis, which results in a marked reduction
in allergen and also possibly LPS exposure.
In adults with high levels of airway eosinophilic inflammation
(defined as a sputum eosinophil count greater than 5%),
macrophage phagocytosis has been shown to be lower, indicating
that eosinophilic inflammation may affect phagocytosis (12).
The toxic effect of eosinophil proteins on the epithelium and
other cells (22, 23) is well known. These proteins may impair
macrophage function.
We have previously shown, however, that sputum eosinophil
count alone may be insufficient to identify ongoing eosinophilia
(24). In children with asthma glucocorticoid treatment results
in reduction of sputum eosinophil count, this could also
be due to drop in recruitment of eosinophils because of
natural resolution of disease process. Corticosteroid therapy
increases eosinophil apoptosis and uptake by macrophages,
thereby increasing the eosinophil protein content within the
macrophages. To differentiate between these processes and to
identify ongoing eosinophilia, we recently developed a novel
marker of eosinophilic inflammation (eosinophil protein content
in airway macrophages) (24).
In this study we hypothesized that airway macrophage
phagocytosis would be lower after reduction of allergen exposure
in children withmild tomoderate asthma. To test our hypothesis,
we compared airway macrophage phagocytosis before and after
allergen avoidance during residence at the High Altitude
Paediatric Asthma Centre in Misurina (1,756m), which offers
residential treatment for children with asthma. In addition,
we assessed the relationship between airway macrophage
phagocytosis and markers of eosinophilic inflammation
(including eosinophilic proteins in airway macrophages) before
their high-altitude residence. According to our understanding,
this is the first study that explores the effect of a high altitude,
with allergen and possibly LPS avoidance, on the phagocytic
function of sputum macrophages in pediatric or adult asthma.
MATERIALS AND METHODS
Study Patients
The study enrolled children aged 7–17 years (n = 62) admitted
to Istituto Pio XII, Misurina, Belluno (High Altitude Paediatric
Asthma Centre) from various cities in Italy between June and
September 2010. Children with a diagnosis of asthma and
residing in the center for 3 weeks or more were included.
The diagnosis of asthma was supported by clinical symptoms
and reversibility testing (> 12% increase in FEV1 after short
acting bronchodilator treatment) (25). The exclusion criteria
were respiratory infection in the preceding 6 weeks, congenital
heart disease and chronic suppurative lung disease, or associated
respiratory conditions such as cystic fibrosis and primary ciliary
dyskinesia.
Study Design
On the day of arrival (T0) the demographic data, exposure
to tobacco smoke, and medications including the doses of
inhaled steroids were recorded. All children underwent clinical
examination; spirometry, FeNO, and skin prick tests were
performed. Spirometry was carried out as per the American
Thoracic Society Guidelines (26). Sputum induction and blood
eosinophil blood counts were performed within 2 days of arrival.
At the end of the stay (T1) the symptoms during the stay and
the treatment received were recorded and sputum induction
was performed. The inhaled corticosteroid dose was converted
to an estimated equipotent daily dose, in accordance with the
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guidelines of the Global Initiative for Asthma (GINA) (25) to
compare the groups. Ethical approval was obtained by the Ethics
Committee for Clinical Research of the Local Heath Authority
in Belluno, and the parents provided written informed consent
for the study. Our investigation was restricted to children with
asthma because no healthy children resided at a high altitude for
the time required by the study.
METHODS
Reagents and Chemicals
All reagents, culture media, and latex beads were purchased from
Sigma–Aldrich (Milan, Italy) unless otherwise specified.
EXHALED NITRIC OXIDE MEASUREMENT
FeNO was measured using a standard technique
complying with the recommendations of the European
Respiratory Society/American Thoracic Society (27), using a
chemiluminescence analyzer (Logan LR 2149; Logan Research
Ltd., Rochester, Kent, UK), and expressed as parts per billion
(ppb).
SPUTUM INDUCTION AND PROCESSING
Sputum was induced and processed as described previously (28,
29). Air-dried cytospins were stained with Diff-Quik. The total
cell count, cell viability, and level of squamous cell contamination
were assessed. The eosinophil differential count was obtained by
counting 400 non-squamous cells and expressed as a percentage.
The children were divided into 2 groups depending on the
differential count on arrival (T0): eosinophilic (≥ 3%) and non-
eosinophilic (< 3%).
Macrophage Eosinophil Protein Content
The image analysis method used was as previously described (24).
Please refer to the online supporting information for details.
Macrophage Culture and Phagocytosis
Assays
The macrophage culture and phagocytosis are described in the
online supporting information.
CONFOCAL MICROSCOPY AND IMAGE
ANALYSIS OF STAPHYLOCOCCUS
AUREUS PHAGOCYTOSIS
After adherence, macrophages were incubated for 2 h with
fluorescein isothiocyanate conjugated, heat-killed Staphylococcus
aureus (Invitrogen Milan Italy) resuspended in RPMI 1640
supplemented with 5% FBS (10:1 ratio of staph aureus/Airway
Macrophage). Please refer to online supporting information for
details of further processing of sample, confocal microscopy,
and image analysis to quantify internalized bacteria. The median
bacterial count/airway macrophage and median maximum
intensity\airway macrophage was calculated for each subject.
Latex Bead Phagocytosis: Phagocytic
Index
After adherence, macrophages were incubated with 2-µm latex
beads (airway macrophage: bead = 1:10) resuspended in RPMI
1640 (supplemented with 5% FBS) for 2 h. Please refer to the
online supporting information for details on the counting of
internalized bacteria. The phagocytic index (beads/100 airway
macrophages) and number of phagocytic macrophages were
calculated.
Statistics
Statistical analysis was performed using GraphPad Prism
6 (GraphPad, San Diego, CA, USA). Patient characteristics
are presented as mean (standard error), median (range
or interquartile range) or percentages. The between-group
comparisons for non-parametric data were made using the
Mann–Whitney test for unpaired data and the Wilcoxon
matched-pair test for paired data as appropriate and proportions
were assessed using Fisher’s exact/chi-square test. Differences
were considered significant when p < 0.05. Linear regression
and Spearman’s co-relations were used to explore the association
between the macrophage eosinophil protein content and
phagocytosis.
RESULTS
Patient Characteristics
The clinical characteristics of 54 children who produced adequate
sputum for cell counts on arrival (T0) are as shown in Table 1.
All children were in GINA Groups 1–3 (with 77.7% of children
in GINA Groups 1 and 2) depending on the treatment in
the previous 3 months prior to the start of residency. Thirty
children had sputum eosinophil counts over 3% and were
therefore assigned to the eosinophilic group, with 24 in the
non-eosinophilic group. The median (range) sputum eosinophil
content in the eosinophilic group was 12% (3–52%). Boys
were predominant in the eosinophilic group. No difference was
observed in FEV1 between the groups. However, the predicted
FEF25−75% was lower and blood eosinophil and FeNo content
were higher in the eosinophilic phenotype (Table 1).
Fifty children produced adequate sputum samples on both
occasions (T0 and T1) for differential counts. No statistical
difference was observed in lung function measurements before
or after their high-altitude stay in a very low ambient allergen
environment. However, after exposure to a high altitude (T1),
they had a significantly lower FeNO (p < 0.001) and eosinophil
counts (p = 0.001) (Table 2, Figure 1d). No difference was
observed in percentage cell viability (Table 1) (all cell types) in
the eosinophilic and non-eosinophilic groups or in the T0 or
T1 samples. The patients who produced an adequate sample for
phagocytosis assay did not differ from those who did in age, lung
function parameters, blood eosinophil counts, or sputum cell
counts. The equipotent inhaled corticosteroid dose was reduced
(p = 0.01) (Table 2) during their stay at the center because the
children were exhibiting fewer symptoms.
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FIGURE 1 | Eosinophilic staining of macrophages at (a) T0 and (b) T1. Graphs showing (c) the median % red hue/airway macrophage ratio, and (d) sputum
eosinophil differential counts at T0 and T1.
Macrophage Eosinophilic Proteins
Example images of red hue in macrophages before and after
residence in Misurina, as an index of eosinophil uptake, are
shown in Figures 1a,b. No significant difference was observed
(p = 0.39) between median airway macrophage red hue
percentage in eosinophilic (n = 30) [median (range)] [5.9 (0.6–
57.6)] and non-eosinophilic asthma (n = 24) [8.7 (0.34–71.2)].
After time spent at a high altitude (T1), the children (n = 43
pairs) had a significantly lower airway macrophage red hue
percentage [p= 0.005] than before T0 (Table 2, Figure 1c).
Macrophage Phagocytosis
Examples of confocal images showing internalized bacteria and
light microscopy images showing latex beads are presented in
Figures 2, 3, respectively. No significant difference (p = 0.3) was
observed between the median bacterial counts in eosinophilic
(n = 16) and non-eosinophilic asthma (n = 8) at T0. After
exposure to a high altitude (T1), the children (n = 19 pairs)
exhibited significantly lower median bacterial counts [Mean
(standard deviation)] [p = 0.006, 39.55 (4.51) vs. 73.26 (39.42)]
than at T0 (Table 3).
Eosinophilic Inflammation and
Phagocytosis
No significant correlation or association was observed between
age, FeNo, pre- and post-bronchodilator lung function (FEV1%
predicted, FVC% predicted, FEF25−75% predicted), blood counts
(total white count, eosinophil count), or sputum parameters
(viability, eosinophil and neutrophil counts) and bacterial uptake
by macrophages (median bacterial count) and median maximum
intensity (bacterial fluorescence). Latex bead phagocytosis
(number of phagocytic macrophages (%) and phagocytic index)
were significantly positively associated with FeNo (p = 0.028)
and blood eosinophils (p = 0.028), but were not associated with
any other parameter. There was a positive correlation between
number of phagocytic macrophages (%) and blood eosinophils
(r = 0.508, p = 0.046). The median airway macrophage red
hue area percentage was not associated with bacterial or latex
phagocytosis parameters. Please refer to online Supplement
Figures 1–4.
DISCUSSION
Alveolar macrophages line the luminal surface and are primary
defense mechanism to protect the lungs from invading pathogens
and pollutants. They initiate and evolve the immune response in
the lung. Overall, the number of macrophages in patients with
asthma is similar to that in healthy individuals (30).
In asthma, two major functionally distinct subsets of
macrophages have been intensively investigated: the M1 and
M2 macrophages. Macrophages have been grouped into M1
and M2 types depending on their function in subjects with
asthma. M1 macrophages are differentiated by bacteria-derived
mediators such as interferon-c and lipopolysaccaride (LPS)
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FIGURE 2 | Confocal image of sputum macrophages cultured with heat-killed fluorescein isothiocyanate-labeled Staphylococci aureus (airway
macrophage:bacteria = 1:10) showing internalized bacteria. (a) Confocal image of bacteria (green) and cytoplasm (red), (b) bacteria alone, and (c) the surface view of
macrophages showing that a majority of the bacteria are internalized.
TABLE 1 | Baseline characteristics of patients.
Eosinophilic
group
(n = 30)
Non-eosinophilic
group
(n = 24)
p-value
Mean age (yr) (SD) 13.51 (± 3.1) 13.02 (± 2.9) 0.55
Sex (male), No. (%) 25 (83.3) 13 (54.1) 0.034
BMI 18.99 (14.4–31.9) 19.99 (12.8–41.1) 0.7
Smoking in house (yes) No.
(%)
12 (40) 7 (29.2) 0.56
Food allergy (yes) No. (%) 14 (46.6) 9 (37.5) 0.58
GINA Classification No. (%) 0.30
1 6 (20) 9 (37.5)
2 17 (56.7) 10 (41.7)
3 7 (23.3) 4 (16.7)
5 0 1 (4.1)
FEV1 % predicted mean
(SE)
106.8 (2.97) 113.7 (3.7) 0.13
FVC% predicted mean (SE) 104.5 (2.22) 107.2 (2.8) 0.45
FEF25−75% predicted Mean
(SE)
98.27 (5.03) 115.9 (6.5) 0.034
Blood eosinophils (%) 7.8 (3.9–12.1) 5.05 (1.9–13.1) 0.014
Median FeNo (ppb) (range) 23.75 (6.3–79.3) 12.8 (12.7–41.1) 0.001
MEDIAN INDUCED SPUTUM (RANGE)
Total cell count × 106 \g
sputum
2.3 (0.39–9.5) 1.7 (0.05–7.2) 0.48
Cell viability (%) 86.5 (59.7–96.4) 88.9 (57.9–100) 0.27
Macrophages (%) 62.5 (1–88) 72.5 (14–97) 0.17
Neutrophils (%) 22 (8–72) 26.5 (3–86) 0.46
(Eosinophilic group ≥ 3% sputum eosinophil differential count). Bold P-values indicates p
< 0.05.
and release various inflammatory cytokines and chemokines,
whereas M2 macrophages have increased phagocytic activity
but are poor at clearing intracellular pathogens. Moreover,
experimental data suggests both M1 and M2 subsets are involved
in asthma (31). In addition there are regulatory macrophages
performing different physiological functions and develop in
response to different stimuli (32). These are vital in regulating
immune responses and reduce inflammation (33). Macrophages
are critical for both innate and acquired immunity and play
TABLE 2 | Lung function, FeNo, sputum differential counts, inhaled
corticosteroids, and macrophage red hue percentage results on arrival (T0), and
after the allergen reduction intervention (3-week residence at a high-altitude
asthma center) (T1).
T0
(n = 50)
T1
(n = 50)
p-
value
FEV1% predicted mean (SE) 109.5 (2.4) 116.0 (2.04) 0.67
FVC% predicted mean (SE) 105.8 (1.81) 105.6 (1.89) 0.91
FEV/FVC ratio % predicted
mean (SE)
103.1 (1.29) 101.8 (1.3) 0.56
FEF25−75% predicted mean
(SE)
105.3 (4.38) 102.9 (4.01) 0.72
Median FeNo (ppb) (range) 18.85 (2.6–79.3) 11.5 (2.1–52.2) 0.0004
ICS treatment* 0.01
No ICS treatment No. (%) 13 (26) 20 (40)
Low daily dose No. (%) 21 (42) 26 (52)
Medium daily dose No. (%) 16 (32) 4 (8)
MEDIAN INDUCED SPUTUM (RANGE)
Total cell count × 106\g
sputum
2.2 (05–9.5) 2.25 (0.26–11.2) 0.24
Macrophages (%) 65 (1–97) 63 (6–87) 0.15
Neutrophils (%) 24.5 (3–86) 32.5 (11–90) 0.006
Eosinophils (%) 3 (0-52) 1 (0–30) 0.001
Lymphocytes (%) 0 (0–2) 0 (0–8) 0.7
Median % area red
hue/airway macrophage
(range) (n = 43 pairs)
7.04 (0.72–71.23) 3.82 (0.41–59.82) 0.005
*GINA classification of equipotent daily dose of inhaled glucocorticosteroids for children
older than 5 years (25). Bold P-values indicates p < 0.05.
a pivotal role in lung defense. Lung macrophages recognize a
wide variety of pathogenic antigens, immune complexes, and
apoptotic or necrotic cells (11). Increased infection in asthma
has led to increased investigation of the clearance of bacterial,
cellular, and inhaled particles by macrophages in patients with
asthma.
Alexis et al. have demonstrated that phagocytosis of opsonised
particles in subjects with mild asthma with airway eosinophilia
was lower as compared to those without eosinophilia. Overall
phagocytosis was comparable between controls and those with
mild intermittent asthma (12). In a similar subjects, phagocytic
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FIGURE 3 | Image of airway macrophages cultured with latex beads (airway
macrophage: bead = 1:10) for 2 h. External beads were digested with xylene.
Internalized beads are preserved (arrow).
activity in airway macrophages decreased by about 50% 6 h after
endotoxin (LPS) inhalation (34).
Fitzpatrick et al. sampled bronchoalveolar lavage
macrophages from children with severe asthma and
demonstrated impaired phagocytosis of S. Aureus. Interestingly
this remained unchanged after LPS stimulation. Moreover,
they have shown that children with severe asthma also had
increased alveolar macrophage apoptosis (35). These later
findings were attributed to imbalance in glutathione homeostasis
(36). Similar findings of reduced phagocytosis of H influenzae
and S aureus were seen in bronchoalveolar lavage and monocyte-
derived macrophages from adults with severe asthma (37). Not
only bacterial uptake but apoptotic cell clearance by lavage
macrophages is reduced in severe asthma as compared to healthy
controls or mild-moderate asthma patients (38).
Studies have demonstrated that severe asthma is associated
with inflammatory mediators such as prostaglandin E2 and
D2, which can suppress the phagocytic activity of alveolar
macrophages (39–41). Recently, Brugha et al. investigated the
phagocytosis of inhalable carbonaceous particle matter by airway
macrophages obtained from the induced sputum of asthmatic
children. Their results demonstrated a 51% lower carbon content
in the macrophages of children with moderate to severe asthma
compared withmild asthma and healthy children (42). Moreover,
the study demonstrated an inverse association between alveolar
macrophage carbon and urinary metabolites of prostaglandin E2
and prostaglandin D2.
The effect of a high altitude on improvement of asthma
symptoms has been attributed to the very low levels of ambient
allergens. In this study, we described for the first time the effect
of residence at a high altitude with markedly reduced allergens
and possibly pollutants (e.g., LPS) on the phagocytic function of
sputum macrophages and markers of eosinophilic inflammation
in children with mild to moderate asthma. According to our
understanding, this is the original study exploring the effect
TABLE 3 | Phagocytosis assay on arrival (T0) and after the allergen reduction
intervention (T1) (3-week residence at a high-altitude asthma center).
Bacterial
phagocytosis
(n = 19 pairs)
T0 T1 p
Mean bacterial count mea (SD) 73.26 (39.42) 39.55 (4.51) 0.006
Mean max intensity (SD) 0.044 (0.010) 0.038 (0.01) 0.08
LATEX BEAD PHAGOCYTOSIS (n = 10 pairs)
Median beads/100 cells (range) 201.0 (71.56–1268) 44.52 (9.8–246.8) 0.003
Mean % phagocytic AM (SD) 57.70 (16.24) 27.86 (16.36) 0.001
Bold P-values indicates p < 0.05.
of reduced allergen\LPS exposure on the phagocytic function
of sputum macrophages in pediatric or adult asthma. The
phagocytosis of heat-killed bacteria in this group of children
decreased after residence at a high altitude and was similar in
eosinophilic and non-eosinophilic phenotypes. We also found
that bacterial phagocytosis was not associated with parameters
of eosinophilic inflammation, including the median airway
macrophage red hue percentage.
Our study strongly suggests that allergen and possibly LPS
exposure is a major contributor to enhanced macrophage
phagocytosis in asthma. The induced sputum macrophage
capacity to phagocytose particles has been demonstrated to
be higher in subjects with mild asthma (12, 43) than in
healthy controls. One possible explanation is that activation
of macrophages is enhanced in asthma. Silva et al showed
that cysteinyl leukotrienes enhanced Fcγ-mediated phagocytosis
in sensitized rats (13). (author?) (28) showed that children
with asthma, after residence in a very low ambient allergen
environment at a high altitude had lower exhaled breath cysteinyl
leukotrienes and leukotriene B4 (28). This might partially explain
our finding of reduced phagocytosis in children withmild asthma
staying in similar conditions. Along with reduction in allergens
there is also possibility of lower level of ambient pollution
including LPS. LPS is known to stimulate macrophages and
therefore reduction would lower phagocytic capacity.
Fitzpatrick et al. sampled bronchoalveolar lavage
macrophages from children with severe asthma and
demonstrated impaired phagocytosis (35) but did not include
children with mild asthma. We were unable to compare our
results of phagocytosis assays with other studies assessing sputum
macrophage phagocytosis because this is the first such study
on children with asthma. In addition, no studies have included
reduction of allergens as an intervention to assess phagocytosis of
sputummacrophages. No difference was observed in the viability
of sputum cells on arrival or after residence at a high altitude that
could have affected the macrophage phagocytic function.
We recently described a novel marker (macrophage
eosinophil protein content measured as red hue percentage)
that identifies ongoing sputum eosinophilia in patients with
asthma and a normal sputum eosinophil count (24). On
admission, children without sputum eosinophilia had similar
airway macrophage red hue percentages as those with sputum
eosinophilia. This suggests the presence of ongoing eosinophilia
in the non-eosinophilic group. Because airway macrophages
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acquire eosinophilic proteins by phagocytizing apoptotic
eosinophils, a lower airway macrophage red hue suggests that
macrophages have ingested fewer eosinophils. Therefore, the
combination of low airway macrophage red hue and low sputum
eosinophil counts suggests a reduction of eosinophil recruitment
to the airways. The reduction of sputum eosinophilia after
residence at a high altitude has previously been demonstrated
(20, 28). In children with asthma glucocorticoid treatment
results in reduction of sputum eosinophil count, this could
also be due to drop in recruitment of eosinophils because of
natural resolution of disease process. Corticosteroid therapy
increases eosinophil apoptosis and uptake by macrophages, thus
increasing the eosinophil protein content within macrophages. It
could be argued that when admitted to the center that supervises
administration of treatment, the improved adherence to
therapy could have contributed to the reduction in eosinophilic
inflammation. However, this is unlikely because the airway
macrophage red hue percentage dropped after residence at
a high altitude, suggesting reduction of eosinophil ingestion
by sputum macrophages and reduced recruitment. Therefore,
using the macrophage red hue measurement has the added
value of helping to differentiate between a reduced sputum
eosinophil count related to treatment and that related to reduced
recruitment of eosinophils.
Although evidence (12) indicates that increased eosinophilic
inflammation is inversely associated with phagocytosis, we did
not find an association between bacterial phagocytosis and
markers of eosinophilic inflammation (including the eosinophilic
proteins in airway macrophages). However, this relationship
must be explored further in children with severe asthma who
have persistent inflammation.
Our study had some limitations. We were unable to recruit
healthy children because they did not reside for 4 weeks at the
high-altitude asthma center. Because of the small amount of
sputum samples obtained from the children, insufficient numbers
of macrophages were obtained to analyze the macrophages for
cell surface markers of activation. It is possible that in vivo
phagocytosis may be affected by other factors that we did
not measure. However, our study results indicating higher
phagocytosis in patients with mild asthma are like those of
inhaled particles in adults in in vivo experiments (43).
In conclusion, induced sputum was successfully used to study
macrophage phagocytosis in children with asthma. The sputum
macrophages in children with mild to moderate asthma after
allergen and possibly lipopolysaccaride avoidance at a high
altitude are less phagocytic. Because activation of macrophages
by allergens in mild asthma enhances phagocytosis, removal of
this stimulus appears to reduce phagocytosis. No association was
observed between phagocytosis and eosinophilic inflammation
markers. Further research is essential to dissect the mechanism
of various types of alveolar macrophage phagocytosis in
asthma.
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